Literature DB >> 920111

Platelet hyperaggregability in young patients with completed stroke.

H C Lou, J D Nielsen, A Bomholt, J Gormsen.   

Abstract

In a consecutive series of 11 young patients with clinical evidence of cerebral infarction, platelet function and plasma lipid levels were examined. The results show that increased platelet aggregability characterizes the patient group as a whole. Hyperlipidemia was frequently found, and the number of heavy smokers was high. It is suggested that all younger patients with cerebrovascular disease are examined with regard to these presumed risk factors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 920111     DOI: 10.1111/j.1600-0404.1977.tb01439.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

1.  Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP.

Authors:  K Winther; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack.

Authors:  H Kiesewetter; F Jung; E M Jung; C Mroweitz; J Koscielny; E Wenzel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients.

Authors:  K Winther; J B Knudsen; J Gormsen; J Jensen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  [Persistent changes in tissue-type plasminogen activator and plasminogen activator inhibitor fibrinolytic parameters in patients following juvenile ischemic cerebral infarct].

Authors:  C Baumgartner; K Huber; F Holzner; K Zeiler; E Auff; B R Binder
Journal:  Klin Wochenschr       Date:  1988-11-15

5.  Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.

Authors:  H J Jürgensen; J Dalsgaard-Nielsen; E Kjøller; J Gormsen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.